Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vibecotamab |
| Trade Name | |
| Synonyms | XmAb14045|SQZ622 |
| Drug Descriptions |
Vibecotamab (XmAb14045) is a bispecific antibody that targets CD123 (IL32A) and CD3, potentially resulting in enhanced killing of tumor cells expressing CD123 (IL32A) (PMID: 37647601). |
| DrugClasses | CD123 (IL3RA) Antibody 14 CD3 Antibody 119 |
| CAS Registry Number | 2138442-13-2 |
| NCIT ID | C127120 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Vibecotamab | Vibecotamab | 0 | 1 |